(in thousands)
| Three Months Ended | Nine Months Ended | |||||||||||||||
|
March 2,
2019 |
March 3,
2018 |
March 2,
2019 |
March 3,
2018 | |||||||||||||
| Operating activities: | ||||||||||||||||
| Net (loss) income | $ | (1,078 | ) | $ | 527 | $ | (951 | ) | $ | 2,083 | ||||||
| Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities: | ||||||||||||||||
| Depreciation and amortization | 794 | 752 | 2,350 | 2,219 | ||||||||||||
| Inventory provisions | 203 | 183 | 568 | 470 | ||||||||||||
| Gain on sale of investments | — | (159 | ) | — | (183 | ) | ||||||||||
| Loss (gain) on disposal of assets | — | 3 | — | (188 | ) | |||||||||||
| Share-based compensation expense | 176 | 116 | 571 | 425 | ||||||||||||
| Deferred income taxes | 113 | 124 | 268 | 186 | ||||||||||||
| Change in assets and liabilities: | ||||||||||||||||
| Accounts receivable | (478 | ) | (551 | ) | (576 | ) | (239 | ) | ||||||||
| Inventories | (1,484 | ) | (598 | ) | (3,315 | ) | (5,232 | ) | ||||||||
| Prepaid expenses and other assets | 614 | 43 | 332 | (572 | ) | |||||||||||
| Accounts payable | (1,561 | ) | 552 | (5,442 | ) | (446 | ) | |||||||||
| Accrued liabilities | 309 | 1,116 | 880 | 1,325 | ||||||||||||
| Other | (86 | ) | (137 | ) | 88 | (140 | ) | |||||||||
| Net cash (used in) provided by operating activities | (2,478 | ) | 1,971 | (5,227 | ) | (292 | ) | |||||||||
| Investing activities: | ||||||||||||||||
| Capital expenditures | (974 | ) | (1,461 | ) | (3,166 | ) | (4,196 | ) | ||||||||
| Proceeds from sale of assets | — | — | — | 276 | ||||||||||||
| Proceeds from maturity of investments | 2,300 | 3,943 | 2,300 | 12,120 | ||||||||||||
| Purchases of investments | (12,500 | ) | — | (17,800 | ) | (3,943 | ) | |||||||||
| Proceeds from sales of available-for-sale securities | — | 648 | — | 913 | ||||||||||||
| Purchases of available-for-sale securities | — | — | — | (265 | ) | |||||||||||
| Other | — | (2 | ) | — | (7 | ) | ||||||||||
| Net cash (used in) provided by investing activities | (11,174 | ) | 3,128 | (18,666 | ) | 4,898 | ||||||||||
| Financing activities: | ||||||||||||||||
| Proceeds from issuance of common stock | 16 | 44 | 219 | 44 | ||||||||||||
| Cash dividends paid | (771 | ) | (763 | ) | (2,305 | ) | (2,284 | ) | ||||||||
| Net cash used in financing activities | (755 | ) | (719 | ) | (2,086 | ) | (2,240 | ) | ||||||||
| Effect of exchange rate changes on cash and cash equivalents | 417 | 1,049 | (617 | ) | 2,189 | |||||||||||
| (Decrease) increase in cash and cash equivalents | (13,990 | ) | 5,429 | (26,596 | ) | 4,555 | ||||||||||
| Cash and cash equivalents at beginning of period | 47,859 | 54,453 | 60,465 | 55,327 | ||||||||||||
| Cash and cash equivalents at end of period | $ | 33,869 | $ | 59,882 | $ | 33,869 | $ | 59,882 | ||||||||
